Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Infusional 5-Fluorouracil in Advanced HCC
NCT00619541Phase 2Completed
- Start
- Jan 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC). Started Jan 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00619541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619541.